Belgium· BE-AMP-SAM378551-00
Vpriv 400 IU
A velaglucerase alfa product containing velaglucerase alfa, registered in Belgium by Takeda Pharmaceuticals International Ireland Branch. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Velaglucerase alfa is registered in 14 of 19 countries.
Countries holding a registration under ATC A16AB10 (velaglucerase alfa), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Velaglucerase alfa · ATC A16AB10
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Velaglucerase Alfa
- Manufacturer
- Takeda Pharmaceuticals International Ireland Branch
- Country
- Belgium (BE)
- ATC code
- A16AB10
- ATC class
- Velaglucerase alfa
- Defined daily dose
- 300 E, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0751321
- be_apb2944981
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Velaglucerase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaVPRIVTakeda Pharmaceuticals International AG Ireland Branch, Dublin
- FinlandVPRIVOrifarm Oy
- SwedenVPRIV 200 E Pulver till infusionsvätska, lösningShire Pharmaceuticals Ireland Limited
- SpainVPRIV 400 UNIDADES POLVO PARA SOLUCION PARA PERFUSIONTakeda Pharmaceuticals International Ag Ireland Branch
- FranceVPRIV 400 unités, poudre pour solution pour perfusionTAKEDA PHARMACEUTICALS INTERNATIONAL (IRLANDE)
- United KingdomVPRIV 400units powder for solution for infusion vialsTakeda UK Ltd
- IrelandVPRIV 400 Units powder for solution for infusionShire Pharmaceuticals Ireland Limited
- IcelandVPRIVTakeda Pharmaceuticals International AG Ireland Branch
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vpriv
- Liechtenstein · Vpriv
- Norway · Vpriv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/61591a87-d9ee-47cc-9034-582881246681 GET /v1/drugs/61591a87-d9ee-47cc-9034-582881246681?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for solution for infusion",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Vpriv 400 IU",
"name_fr": "Vpriv 400 IU",
"name_nl": "Vpriv 400 IU",
"amp_code": "SAM378551-00",
"strengths": [
"400.0000",
"400.0000",
"400.0000"
],
"pack_count": 3,
"substances": [
"Velaglucerase Alfa",
"Polysorbate 20"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Velaglucerase Alfa",
"authorisation_numbers": [
"EU/1/10/646/005",
"EU/1/10/646/002",
"EU/1/10/646/006"
]
}See everything about velaglucerase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.